LATAM Supplement RegistrationLatin America Supplement Registration Framework
A comprehensive guide to the regulatory frameworks for dietary and food supplements across Latin American markets, covering ANVISA, COFEPRIS, INVIMA, and the shift from registration to notification models.

On this page · 11 sections
- 1The Latin American Supplement Landscape: A Patchwork of Regulation
- 2Brazil: The ANVISA Revolution (RDC 243/2018)
- 3Mexico: COFEPRIS and the 'Aviso de Funcionamiento'
- 4Colombia: The Rigour of INVIMA
- 5Argentina: ANMAT and the Food Code
- 6Peru: The DIGEMID Pharmaceutical Hurdle
- 7Chile: The Dual Authority System
- 8The Local Legal Representative (LLR) Requirement
- 9Labelling and Claims: The Red Lines
- 10MERCOSUR and the Quest for Harmonisation
- 11Strategic Guidance: Navigating a Moving Target
How does LATAM Supplement Registration apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01The Latin American Supplement Landscape: A Patchwork of Regulation
For manufacturers in the dietary supplement and nutraceutical sectors, Latin America represents one of the most promising yet complex regions for expansion. Valued at billions of dollars and growing steadily, the market is characterised by a fragmented regulatory environment where the same product may be classified as a food, a supplement, or even a pharmaceutical drug, depending entirely on which border it crosses. Understanding the nuances of each national health authority—from Brazil's ANVISA to Mexico's COFEPRIS—is not just a matter of compliance; it is a critical business strategy.
The diversity of the region's regulatory frameworks means there is no 'one-size-fits-all' entry strategy. While some countries, like Brazil, have recently modernized their laws to create a dedicated 'Food Supplement' category, others still rely on older decrees that shoehorn supplements into broader food or medicine categories. This disparity creates a 'patchwork' effect that requires local expertise and meticulous documentation for every SKU in a company's portfolio. The complexity is compounded by the fact that many countries are currently in a state of transition, moving from older, rigid registration systems to more modern, risk-based notification models, but often retaining legacy requirements that create a hybrid burden for importers.
This guide provides a deep dive into the primary markets of the region, the regulatory bodies that govern them, and the specific hurdles manufacturers face—including the mandatory requirement for Local Legal Representatives (LLR), the strict limits on health claims, and the ongoing (but slow) efforts toward regional harmonisation through blocs like MERCOSUR. We will also explore the critical importance of gmp compliance and how documentation like sops play a vital role in the registration dossier.
02Brazil: The ANVISA Revolution (RDC 243/2018)
Brazil is the largest market in Latin America, and its regulatory body, the Agência Nacional de Vigilância Sanitária (ANVISA), is widely considered the most sophisticated and influential in the region. Historically, supplements in Brazil were split across multiple categories, including 'Vitamin and Mineral Supplements,' 'Athlete Supplements,' and 'Foods with Functional Claims.' This led to significant confusion for both consumers and manufacturers regarding what claims could be made and what registration path was required.
In 2018, ANVISA enacted a landmark regulatory framework, centered on Resolution RDC 243/2018. This resolution established a single, unified category for 'Food Supplements' (Suplementos Alimentares), defined as products for oral administration, presented in pharmaceutical forms, intended to supplement the diet of healthy individuals with nutrients, bioactive substances, enzymes, or probiotics 1.
Registration vs. Notification in Brazil
One of the most significant changes introduced by the new framework was the shift toward a notification-based model for the majority of products. Under RDC 240/2018, most supplements are now exempt from prior sanitary registration. Instead, companies must submit a 'Communication of Start of Manufacture or Import' to their local health authority (Visa local) 2.
However, registration with ANVISA remains mandatory for products that pose higher perceived risks, specifically:
- Supplements containing probiotics or enzymes: These require a full technical dossier demonstrating safety and the specific strain's identity.
- Supplements containing new ingredients (Novel Foods): Any ingredient not previously evaluated by ANVISA for safety in food must undergo a rigorous safety assessment.
- Products making specific functional or health claims: While there is a 'Positive List' of pre-approved claims, any new claim requires a scientific dossier to be submitted and approved by ANVISA.
For these registered products, the dossier must include comprehensive safety data and, in the case of probiotics, evidence of the specific strain's efficacy. The exemption from registration for vitamins and minerals has drastically reduced time-to-market, but it has increased the burden of responsibility on the manufacturer to ensure their formulation matches the 'Positive Lists' of ingredients and limits published in Normative Instruction IN 28/2018 (and its frequent updates, such as IN 284/2024) 2. Companies must also ensure their quality-management-system is robust enough to handle the post-market surveillance required for notified products.
03Mexico: COFEPRIS and the 'Aviso de Funcionamiento'
Mexico represents the second-largest opportunity in the region. Regulation is overseen by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). In Mexico, 'Suplementos Alimenticios' are defined under Article 215, Section V of the General Health Law as products based on herbs, plant extracts, traditional foods, or fruit concentrates, with or without added vitamins/minerals, intended to increment total dietary intake 5.
Unlike Brazil's formal registration dossiers for high-risk items, Mexico primarily operates on a 'Notice of Operation' (Aviso de Funcionamiento) system for the establishment. The products themselves do not technically require a 'Sanitary Registry' (Registro Sanitario) number like a drug would. However, this lack of a formal registry does not mean the market is unregulated. COFEPRIS maintains strict control over three specific areas: ingredients, labelling, and advertising.
The Import Hurdle: PSPI
For foreign manufacturers, the biggest challenge is the Prior Sanitary Import Permit (Permiso Sanitario Previo de Importación or PSPI). To grant this permit, COFEPRIS conducts a review of the product's formula and label. If the formula contains a prohibited plant (as per the 'Agreement on Prohibited and Permitted Plants for Teas') or exceeds vitamin limits, the permit will be denied 1.
Mexico has also implemented a 'Clean Label' initiative that involves front-of-package warning octagons for products high in calories, sugars, sodium, or fats. While many supplements are exempt from these seals due to their low calorie content per serving, any supplement that uses sweeteners or has higher caloric density must be carefully evaluated to ensure correct labelling, as incorrect labelling can lead to product seizures at the border.
04Colombia: The Rigour of INVIMA
Colombia is often cited by regulatory affairs professionals as one of the most challenging markets in the region due to the stringent requirements of the Instituto Nacional de Vigilância de Medicamentos y Alimentos (INVIMA). Unlike the notification-heavy models of Mexico and parts of Brazil, Colombia requires a formal Sanitary Registry (Registro Sanitario) for all 'Suplementos Dietarios' before they can be sold 2.
The primary legal framework is Decree 3249 of 2006, which governs the manufacture, commercialization, and labelling of dietary supplements. INVIMA treats supplements with a level of scrutiny that approaches pharmaceutical standards in some aspects, particularly regarding manufacturing quality 1.
- Mandatory GMP: Manufacturers must demonstrate compliance with Good Manufacturing Practices. For foreign plants, this involves submitting a Certificate of Free Sale (CFS) and, critically, a GMP certificate issued by the competent authority in the country of origin. INVIMA may also conduct its own inspections of foreign plants.
- Upper Limits: Colombia adheres strictly to the Tolerable Upper Intake Levels (UL) for vitamins and minerals. Products formulated for the US market often exceed these levels and must be reformulated for Colombia 4.
- Stability Testing: INVIMA requires stability studies to support the shelf-life claims of the product, often following the ICH guidelines for Zone IVb (hot and humid), which covers the Colombian climate. This often means providing 'accelerated' and 'long-term' stability data.
The registration process can take between 6 to 12 months, and the resulting registry number must be clearly printed on every label. Any change to the formula, the manufacturing site, or even the primary packaging material requires a 'Modification of Registry' filing, which can take several months to process. This makes Colombia a high-barrier market that requires significant lead time and investment.
05Argentina: ANMAT and the Food Code
In Argentina, the Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) oversees supplements through the Instituto Nacional de Alimentos (INAL). Supplements are categorised as 'Suplementos Dietarios' under Article 1381 of the Código Alimentario Argentino (CAA) 4.
The registration process in Argentina is structured around two fundamental registrations:
- RNE (Registro Nacional de Establecimiento): The importer or local manufacturer must have a registered establishment license. This involves a physical inspection of the warehouse or factory by INAL or provincial health authorities to ensure it meets haccp or similar hygiene standards.
- RNPA (Registro Nacional de Producto Alimenticio): Each individual product must be registered and assigned a unique number. The dossier includes the quantitative formula, the labelling project, and the justification for any non-standard ingredients 1.
Argentina is particularly strict regarding the 'pharmaceutical form.' If a product is presented in a way that suggests a drug (e.g., certain injectable forms, or very high concentrations that approach therapeutic levels), ANMAT will reject its food status. Furthermore, for supplements, Argentina requires the intervention of a Technical Director (Director Técnico), who must be a licensed pharmacist or a professional with equivalent qualifications, to sign off on the safety and quality of the products through a digital signature in the SIFeGA system 5.
06Peru: The DIGEMID Pharmaceutical Hurdle
Peru represents one of the most unique and challenging regulatory models in Latin America. While most countries place supplements under their food authorities, Peru often classifies them under the Dirección General de Medicamentos, Insumos y Drogas (DIGEMID), which is the agency responsible for pharmaceuticals 2.
In Peru, many products that would be 'supplements' elsewhere fall under the category of 'Productos Galénicos' or 'Recursos Terapéuticos Naturales.' If a product contains vitamins above a certain threshold or includes specific botanicals, it requires a full Sanitary Registry as a pharmaceutical product. This involves:
- Stringent GMP Requirements: The manufacturing site must be certified as meeting pharmaceutical-grade GMP standards.
- Technical Director Requirement: A licensed pharmaceutical chemist must act as the technical director for the importing company.
- Post-Market Surveillance: A robust pharmacovigilance system is mandatory to monitor and report adverse reactions.
This pharmaceutical classification significantly increases the cost and time of entry, as the evaluation by DIGEMID is much more thorough than a standard food review. For products that fit the 'Food' definition, the registry is handled by DIGESA (the food authority), but the boundary between DIGESA and DIGEMID is notoriously difficult to navigate.
07Chile: The Dual Authority System
Chile operates under the Reglamento Sanitario de los Alimentos (RSA), Decree 977/96. The regulation of supplements is divided between two entities: the Secretaría Regional Ministerial de Salud (SEREMI) and the Instituto de Salud Pública (ISP) 1.
In most cases, 'Suplementos Alimentarios' are considered a category of food and are regulated by the SEREMI. There is no prior sanitary registry number for individual products; instead, the importer must obtain a 'Certificate of Customs Destination' (CDA) and an 'Authorization for Use and Disposal' (Uso y Disposición) for each shipment 5.
The ISP enters the picture when there is 'classification doubt.' If a product contains high doses of vitamins or ingredients not listed in the RSA, or if it makes therapeutic claims, it may be classified as a medicine. Manufacturers often perform a 'Consultation of Applicable Control Regime' (Régimen de Control Aplicable) with the ISP to confirm their product is indeed a food supplement and not a pharmaceutical 1. This process is essential for 'novel' products that don't fit the standard Chilean food code definitions.
08The Local Legal Representative (LLR) Requirement
One universal truth across almost all Latin American markets is the requirement for a Local Legal Representative (LLR). For a foreign company without a local subsidiary, the LLR is the entity that 'owns' the sanitary registry or notification and is legally responsible for the product's safety, quality, and compliance in the eyes of the health authority 1.
The LLR is not just a mailing address; they are often required to have their own sanitary license and are subject to inspections. This creates a strategic dilemma for foreign manufacturers: should they appoint their distributor as the LLR, or hire an independent third-party regulatory firm? Appointing a distributor as the LLR can be risky, as the distributor then controls the brand's ability to stay in the market. If the relationship sours, the manufacturer may find that their product registration is 'held hostage' by the distributor, requiring a costly and time-consuming transfer of registry. Many companies now opt for 'independent' LLRs to maintain control over their intellectual property and market access.
Key responsibilities of the LLR include:
- Submitting the registration or notification dossiers and paying all health authority fees.
- Acting as the point of contact for health authority inquiries, audits, or product recall notifications.
- Managing Nutrivigilance (monitoring adverse reactions related to supplement consumption).
- Ensuring that any changes in the product (formula, label, manufacturer) are updated with the regulator through a change-control process.
09Labelling and Claims: The Red Lines
In Latin America, the distinction between a 'Food Supplement' and a 'Medicine' is largely drawn at the claim level. While the US allows 'Structure/Function' claims with a disclaimer, Latin American regulators generally operate on a 'Positive List' basis. If a claim is not explicitly authorised in the local regulation, it cannot be used without a long and expensive scientific evaluation 5.
Prohibited Claims
Across all LATAM markets, supplements are strictly prohibited from making therapeutic, curative, or diagnostic claims. A label cannot state that a product 'cures diabetes,' 'prevents cancer,' or even 'reduces inflammation' in a way that implies a disease state. In Mexico, labels are even prohibited from showing images of organs or parts of the body (such as a heart or a liver) that might suggest a therapeutic effect on those specific organs 3.
Language and Formatting
Labels must be in the local language (Spanish for most of the region, Portuguese for Brazil). While multi-lingual labels are sometimes tolerated, the local language text must be prominent and meet specific font size requirements. Mandatory warnings are common, such as 'Keep out of reach of children' or specific warnings for pregnant women, nursing mothers, and children. In Brazil, the label must also state the specific group the supplement is intended for (e.g., '19 years and older').
| Country | Mandatory Statement Example | Primary Regulator | Model |
|---|---|---|---|
| Brazil | Suplemento Alimentar | ANVISA | Notification (mostly) |
| Mexico | Este producto no es un medicamento | COFEPRIS | Notice of Operation |
| Colombia | Este producto es un suplemento dietario, no es un medicamento... | INVIMA | Registry |
| Argentina | Suplemento Dietario | ANMAT | Registry (RNPA) |
| Chile | Suplemento Alimentario | SEREMI / ISP | Authorization |
| Peru | Suplemento Vitamínico / Dietético | DIGESA / DIGEMID | Registry |
10MERCOSUR and the Quest for Harmonisation
The Southern Common Market (MERCOSUR)—comprising Argentina, Brazil, Paraguay, and Uruguay—has long sought to harmonise food and supplement regulations to facilitate trade. Several GMC (Grupo Mercado Común) resolutions have been adopted, such as GMC Res 01/12 on Nutritional Complementary Information and GMC Res 27/22 on food additives 1 4.
However, 'harmonisation' in MERCOSUR does not mean 'automatic recognition.' While the countries agree on general labelling principles and some additive lists, each state party must still 'internalise' the resolution into their national law. Furthermore, significant differences remain in how each country classifies specific ingredients, especially botanicals and 'new' substances. A product approved in Brazil is not automatically legal in Argentina; it still requires a local RNPA and must comply with the specific Argentine limits 2.
A recent bright spot in regional cooperation is the February 2025 agreement between Argentina's ANMAT and Paraguay's DINAVISA, which establishes mutual recognition of their food control systems for certain categories 2. Such bilateral agreements may pave the way for a more integrated regional market in the future, but for now, manufacturers must treat each country as a separate regulatory silo. The Pacific Alliance (Chile, Colombia, Mexico, Peru) also has working groups on regulatory cooperation, but progress on supplements has been slower than in the cosmetics or medical device sectors.
11Strategic Guidance: Navigating a Moving Target
The most important piece of advice for any manufacturer entering Latin America is that rules change frequently. Health authorities like ANVISA and COFEPRIS are increasingly active in updating their 'Positive Lists' of ingredients and additives. For instance, ANVISA's IN 284/2024 recently updated the list of authorised constituents, reflecting new scientific evidence on safety and efficacy 2.
To succeed in the region, companies should follow a structured approach:
- Formula Feasibility: Before finalizing a product, check every ingredient against the specific 'Positive List' of the target country. Pay close attention to the source of the ingredient (e.g., specific plant part) and the daily dosage. A formula that is 'clean' in the US might have a 'prohibited' additive in Colombia.
- Choose your LLR Wisely: Prioritize LLRs who have a deep understanding of the local 'grey areas' and who offer transparency in their dealings with health authorities. The ability to handle capa processes for regulatory non-conformities is essential.
- Audit your Supply Chain: Regulatory authorities are increasingly looking beyond the product to the facility. Ensure your manufacturing sites have up-to-date GMP certifications that will be recognised by INVIMA or ANMAT. In some countries, a supply-chain-traceability audit may be required for certain high-risk ingredients.
- Monitor for Changes: Subscribe to regulatory update services or work with local consultants who can flag new resolutions before they become law. The five-year transition period for Brazil's RDC 243/2018 ended in July 2023, leaving many non-compliant products stranded 2.
"In Latin America, compliance is not a hurdle to be cleared once; it is an ongoing process of monitoring, adapting, and documenting. What is compliant today may be non-compliant tomorrow due to a new resolution or a shift in the authority's interpretation of existing law. The trend toward digitalization (like Argentina's SIFeGA) is increasing transparency but also making enforcement more efficient."
Ultimately, while the regulatory burden is high, the rewards of the Latin American supplement market are significant for those who take the time to build a robust, compliant foundation. By treating quality and regulatory affairs as core components of their market entry strategy, manufacturers can mitigate risk and build long-term trust with consumers and regulators alike. Success in the region requires a blend of global quality standards and local regulatory agility.
Frequently asked questions
Q.Do Latin American countries regulate supplements like the US?+
No. Most Latin American markets treat supplements as foods rather than a distinct category like the US DSHEA framework, and many require pre-market registration or notification with a national health authority — for example ANVISA in Brazil or COFEPRIS in Mexico — before sale.
Q.What is the difference between notification and registration?+
Under a notification model you inform the authority and may sell once the notification is filed (or after a short waiting period). Under a registration model the authority must affirmatively approve the product first, which can take months. The model varies by country and by product category.
Q.Do I need a local legal representative?+
In most Latin American markets, yes — a locally established legal entity or authorised holder must hold the registration and take responsibility for the product. Choosing this partner carefully matters because the registration often belongs to them.
Q.Are health claims allowed on supplements in Latin America?+
Claim rules are generally stricter than in the US. Many countries prohibit disease claims outright and restrict permitted wording to approved lists. Labels usually must be in the local language (Spanish or Portuguese) with country-specific mandatory statements.
Primary sources
Want to see how LATAM Supplement Registration could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
